Tumor cell-endothelial cell interactions: Evidence for roles for lipoxygenase products of arachidonic acid in metastasis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 4, 1997, Pages 295-300

  Damtew, B ^a   Spagnuolo, P J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; CALCIMYCIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; BREAST TUMOR; CANCER CELL; CELL INTERACTION; CELL LINE; CHORIOCARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; METASTASIS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030981281     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90573-1     Document Type: Article

References (30)

1. Liotta L. A., Rao C. W., Wewer U. M. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55: 1037-1057.
2. Weiss L., Orr F. W., Honn K. V. Interactions involving cancer cells and the microvasculature: A rate regulator for metastasis. Clin Exp Metastasis 1989; 7: 127-167.
3. Weiss L., Orr F. W., Honn K. V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J 1988; 2: 12-21.
4. Crissman J. D., Hatfield J., Menter D. G., Sloane B. F., Honn K. V. Morphological study of the interaction of intravascular tumor cells, endothelial cells and subendothelial matrix. Cancer Res 1988; 48: 4065-4072.
5. Crissman J. D., Hatfield J. S., Schaldenbrand J., Sloane B. F., Honn K. V. Arrest and extravasation of B16 amelanotic melanoma in murine lung: Light and electron microscopic study. Lab Invest 1985; 53: 470-478.
6. Honn K. V., Cicone B., Skoff A. Prostacyclin: A potent antimetastatic agent. Science 1981; 212: 1270-1272.
7. Honn K. V., Grassi I. M., Diglio C. A. et al. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(5)-HETE-induced endothelial cell retraction. FASEB J 1989; 3: 2285-2293.
8. Rice G. E., Gimborne M. A., Jr, Bevilacqua M. P. Tumor cellendothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol 1988; 133: 204-210.
9. Honn K V., Bockman R. S., Marnett C. J. Prostaglandins and cancer. A review of tumor initiation through metastasis. 1981; Prostaglandins 21: 833-850.
10. Rolland P. H., Martin P. M., Jacquemier J. et al. Prostaglandins in human breast cancer: Evidence suggesting that an elevated prostaglandin production in a marker of metastatic potential for neoplastic cells. J Natl Cancer Inst 1980; 64: 1061-1070.
11. Furuta Y., Hall E. R., Sanduja S. et al. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res 1988; 48: 3002-3007.
12. Hial V., Horakowa Z., Shaff R. E. et al. Alterations of tumor growth by aspirin and indometacin. Studies with two transplantable tumor in mice. Eur J Pharmacol 1976; 37: 367.
13. Thun M., Namboodiri M. M., Heath C. W. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-1596.
14. Ford-Hutchinson A. W. Leukotrienes: Their formation and role as inflammatory mediators. Federation Proc 1985; 44: 25-29.
15. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984; 63: 55-63.
16. Tai H. H., Yan B. Studies on the thromboxane synthesizing system in human platelet microsomes. Biochem Biophys Acta 1978; 531: 286-294.
17. Bennett A., Houghton J., Leape D.J. et al. Tumor growth and response to treatment: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Br J Pharmacol 1978; 63: 356-375.
18. Honn K. V., Grassi I. M., Fitzgerald L. A., Umbarger L. A., Diglio C. A., Taylor J. D. Lipoxygenase products regulate IRGpIIb/IIIa receptor mediated adhesion of tumor cells to endothelial cells, subendothelial matrix and fibronectin. Proc Soc Exp Biol Med 1988; 189: 130-135.
19. Levine L Atachidonic acid transformation and cancer. Adv Cancer Res 1981; 35: 49-73.
20. Gimbrone M. A. Jr. Culture of vascular endothelium. Prog Hematol 1976; 3: 1-28.
21. Kramer A. H., Gonzalez R., Nicolson G. L. Metastatic tumors adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 1980; 26: 639-645.
22. Snyder D. S., Castro R., Desforges J. F. 5-lipoxygenase metabolites of arachidonic acid modulate proliferation of malignant hematopoietic cell lines. Blood 1987; 70(Suppl): 185a.
23. Pober J. S., Bevilacqua M. P., Mendrick D. L. et al. Two distinct monokines, interleukin-1 and tumor necrosis factor each independently induces biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-1689.
24. 2 and prostacyclin. Pharmacol Rev 1979; 30: 293-331.
25. 2 levels in human breast carcinoma. Prostagland Med 1979; 2: 133-139.
26. Hubbard W. C., Alley M. C., McLemore T. L., Boyd M. R. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, and ovarian tumors. Cancer Res 1988; 48: 4770-4775.
27. Feller N., Malachi T., Halbrecht I. Prostaglandin E2 and cyclic AMP levels in human breast tumors. J Can Res Clin Oncol 1979; 93: 275-280.
28. Lundholm K., Gelin J., Hyltander A. et al. Anti-inflammatory treatment may prolong survival in undernoursished patients with metastatic solid tumors. Cancer Res 1994; 54: 5602-5606.
29. Gelin J., Anderson C., Lundholm K. Effects of indomethacin, cytokines and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res 1991; 51: 880-885.
30. Furuta Y., Hunter N., Barkely T. et al. Increase in radioresponse of murine tumors by treatment with indomethacin. Cancer Res 1988; 48: 3008-3013.